Biomedical Engineering Reference
In-Depth Information
361. Hinoshita E, Taguchi K, Inokuchi A, Uchiumi T, Kinukawa N, Shimada M, Tsuneyoshi
M, Sugimachi K, Kuwano M. 2001. Decreased expression of an ATP-binding cassette
transporter, MRP2, in human livers with hepatitis C virus infection. J Hepatol 35: 765-
773.
362. Fromm MF, Kauffmann HM, Fritz P, Burk O, Kroemer HK, Warzok RW, Eichelbaum M,
Siegmund W, Schrenk D. 2000. The effect of rifampin treatment on intestinal expression
of human MRP transporters. Am J Pathol 157: 1575-1580.
363. Cui Y, Konig J, Buchholz JK, Spring H, Leier I, Keppler D. 1999. Drug resistance and
ATP-dependent conjugate transport mediated by the apical multidrug resistance protein,
MRP2, permanently expressed in human and canine cells. Mol Pharmacol 55: 929-
937.
364. Koike K, Kawabe T, Tanaka T, Toh S, Uchiumi T, Wada M, Akiyama S, Ono M, Kuwano
M. 1997. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA
enhances drug sensitivity in human hepatic cancer cells. Cancer Res 57: 5475-5479.
365. Borst P, Evers R, Kool M, Wijnholds J. 1999. The multidrug resistance protein family.
Biochim Biophys Acta 1461: 347-357.
366. Evers R, Kool M, van Deemter L, Janssen H, Calafat J, Oomen LC, Paulusma CC,
Oude Elferink RP, Baas F, Schinkel AH, Borst P. 1998. Drug export activity of the
human canalicular multispecific organic anion transporter in polarized kidney MDCK
cells expressing cMOAT (MRP2) cDNA. J Clin Invest 101: 1310-1319.
367. Evers R, de Haas M, Sparidans R, Beijnen J, Wielinga PR, Lankelma J, Borst P. 2000. Vin-
blastin and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated
with glutathione export. Br J Cancer 83: 375-383.
368. Huisman MT, Chhatta A, van Tellingen O, Beijnen JH, Schinkel AH. 2005. MRP2
(ABCC2) transports taxanes and confers paclitaxel resistance and both processes are
stimulated by probenecid. Int J Cancer 116: 824-829.
369. Kool M, van der Linden M, de Haas M, Scheffer GL, De Vree JML, Smith AJ, Jansen G,
Peters GI, Ponne N, Scheper RJ, et al. 1999. MRP3, an organic anion transporter able to
transport anti-cancer drugs. Proc Natl Acad SciUSA96:6914-6919.
370. Dietrich CG, Ottenhoff R, de Waart DR, Oude Elferink RP. 2001. Role of MRP2 and
GSH in intrahepatic cycling of toxins. Toxicology 167: 73-81.
371. Konno T, Ebihara T, Hisaeda K, Uchiumi T, Nakamura T, Shirakusa T, Kuwano M,
Wada M. 2003. Identification of domains participating in the substrate specificity and
subcellular localization of the multidrug resistance proteins MRP1 and MRP2. J Biol
Chem 278: 22908-22917.
372. Keppler D, Leier I, Jedlitschky G. 1997. Transport of glutathione conjugates and glu-
curonides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 378: 787-
791.
373. Xiong H, Turner KC, Ward ES, Jansen PL, Brouwer KL. 2000. Altered hepatobiliary
disposition of acetaminophen glucuronide in isolated perfused livers from multidrug
resistance-associated protein 2-deficient TR(-) rats. J Pharmacol Exp Ther 295: 512-
518.
374. Xiong H, Suzuki H, Sugiyama Y, Meier PJ, Pollack GM, Brouwer KLR. 2002. Mecha-
nisms of impaired biliary excretion of acetaminophen glucuronide after acute phenobar-
bital treatment or phenobarbital pretreatment. Drug Metab Dispos 30: 962-969.
Search WWH ::
Custom Search